PubMed Health⌕ Search

Biomedical subjects

J Wulff

Publications and source records attributed to J Wulff.

18 recordsLinked to original sources
PubMed1997

Flow characteristics of the Hemopump: an experimental in vitro study.

BACKGROUND: The Hemopump (DLP/Medtronic) has been in clinical use for about 7 years. There is still no adequate way of determining actual output from the three available pump systems in the clinical situation. If the pump is completely stopped during weaning from the device, there is a possibility of back-leakage through the pump, endangering the patient from regurgitation into the left ventricle. It can also make it more difficult to judge the recovery of heart function because of a volume load of the left ventricle. The aim of this study was to evaluate in a standardized, experimental in vitro model the output from three different-sized Hemopump catheters at various pressure levels and to quantify the back-flow through the pumps. METHODS: The Hemopump models were tested in an in vitro study regarding total outflow at various speeds at three pressure levels. The back-flow through the pumps was also measured with the pumps at a complete stop. RESULTS: The outflow from the Hemopumps ranged from 0.4 to 4.5 L/min, depending on which pump and speed were used. Variations in total output, depending on speed and various pressure settings, could be up to 0.4 L/min. Back-flow through the pump into the left ventricle may be as great as 1.6 L/min. CONCLUSIONS: The flow outputs from the different Hemopump models were reproducible over time and were closely related to the resistance of the model. The Hemopump, if not running, can induce substantial regurgitation through the pump into the left ventricle.

Blood Flow Velocity↗
PubMed1987

Treatment of a post-traumatic headache.

After fantasy work in a trance state a patient with post-traumatic headaches experienced some relief as other symptoms appeared, and then total relief along with the disappearance of the other symptoms. He was able to withdraw from all medications.

Behavior Therapy↗
PubMed1985

Purulent pericarditis in children. Review and case report.

Acute purulent pericarditis is infrequent in children. Only around 200 cases have been reported in the western literature in the past 25 years (1-10). From the Scandinavian countries only two cases have been described (6, 7). Purulent pericarditis is usually a complication of upper respiratory tract infection. Mortality is very high in unrecognized or inadequately treated cases. Early diagnosis and appropriate treatment with adequate surgical drainage and antimicrobial therapy are vitally important for the outcome.

Child, Preschool↗
PubMed1975

Cast vs. wrought cobalt-chromium surgical implant alloys.

The measured tensile and fatigue strengths of wrought and heat-treated cobalt chromium-molybdenum-carbon alloys such as HS21 were found to be more than twice those of as cast alloys of the same composition. The resistance of wrought HS21 to crevice corrosion at metal-Teflon contacts in isotonic salt solution at 37 degrees C was found to be considerably greater than that of cast HS21, wrought HS25, wrought MP35, or 316L stainless steel which are currently used for surgical implants. The increased crevice corrosion resistance and mechanical strength of wrought HS21 as compared to as cast HS21 was attributed to greater chemical and structural homogeneity as well as to finer grain size and distribution of secondary phases. Fabrication of shaped implants from wrought HS21 is possible by techniques currently used for the fabrication of industrial parts from other wrought cobalt-chromium base alloys.

Carbon↗
PubMedDate not supplied

[Hemostasis and fibrinolysis in acute lymphoblastic leukemia (ALL) in childhood--analysis of life-threatening bleeding].

66 children with ALL, who were admitted to the University Children's Hospital at Münster for treatment according to the BFM protocol 79/81, presented initially with the following abnormal hemostatic parameters: Prolongation of bleeding time (89%), thrombocytopenia (83%), pathological prothrombin time (69%), increased FDP (32%, reduced F XIII (33%), abnormal short PTT (34%). There was a significant discrepancy between immunologically and functionally measured fibrinogen, which is only partially explained by the presence of FDP. Patients with T-cell leukemia (n = 11) had significantly higher WBC, longer prothrombin times, and lower fibrinogen levels than patients with Non-T/non-B ALL. The initial coagulation parameters did not discriminate the 6 patients who presented life threatening bleeding episodes. The two patients with high blast count (350 000 and 548 000/mm3) and T-ALL had intracranial bleeding before therapy started; in one of them vascular infiltration of blast cells was demonstrated at autopsy. Two other patients had bacterial infections, which in one case led to local bleeding into the lungs and in the other case to DIC. Two further children presented intracranial bleeding episodes which could be associated with asparaginase therapy. 5 of the 6 patients with life threatening episodes had a platelet count of more than 35 000/mm3.

Adolescent↗